Drug Patents owned by Btcp Pharma
1. Drug name - LAZANDA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9814705 | BTCP PHARMA | Intranasal spray device containing pharmaceutical composition |
Jan, 2024
(1 year, 3 months from now) | |
| US9078814 | BTCP PHARMA | Intranasal spray device containing pharmaceutical composition |
Jan, 2024
(1 year, 3 months from now) | |
| US8889176 | BTCP PHARMA | Method of managing or treating pain |
Jan, 2024
(1 year, 3 months from now) | |
| US8216604 | BTCP PHARMA | Method of managing or treating pain |
Oct, 2024
(2 years from now) | |
| US9731869 | BTCP PHARMA | Container |
Jan, 2032
(9 years from now) | |
Drugs and Companies using FENTANYL CITRATE ingredient
Treatment: Management of breakthrough pain in patients with cancer
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.1MG BASE | SPRAY, METERED;NASAL | Prescription |
| EQ 0.3MG BASE | SPRAY, METERED;NASAL | Discontinued |
| EQ 0.4MG BASE | SPRAY, METERED;NASAL | Prescription |
2. Drug name - SUBSYS
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10610523 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US8835459 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US10016403 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US9241935 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US8835460 | BTCP PHARMA | Sublingual fentanyl spray and methods of treating pain |
Jan, 2027
(4 years from now) | |
| US9642797 | BTCP PHARMA | Sublingual fentanyl spray and methods of use to treat pain |
Jan, 2027
(4 years from now) | |
| US9289387 | BTCP PHARMA | Method of treating pain by administering sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US9642844 | BTCP PHARMA | Sublingual fentanyl spray |
Jan, 2027
(4 years from now) | |
| US8486973 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(7 years from now) | |
| US8486972 | BTCP PHARMA | Sublingual fentanyl spray |
Apr, 2030
(7 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.1MG | SPRAY;SUBLINGUAL | Prescription |
| 0.2MG | SPRAY;SUBLINGUAL | Prescription |
| 0.4MG | SPRAY;SUBLINGUAL | Prescription |
| 0.6MG | SPRAY;SUBLINGUAL | Prescription |
| 0.8MG | SPRAY;SUBLINGUAL | Prescription |
| 1.2MG | SPRAY;SUBLINGUAL | Prescription |
| 1.6MG | SPRAY;SUBLINGUAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.